FDA.reportPublic FDA data

Zeposia 37-Day Starter Kit (7-Day Starter Pack and 0.92 MG 30 count Bottle)

RxCUI
2288431
RxNorm name
Zeposia 37-Day Starter Kit (7-Day Starter Pack and 0.92 MG 30 count Bottle)
Display name
Zeposia 37-Day Starter Kit (7-Day Starter Pack and 0.92 MG 30 count Bottle)
Full name
Zeposia 37-Day Starter Kit (7-Day Starter Pack and 0.92 MG 30 count Bottle)
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:09

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZEPOSIA 7-Day Starter PackOZANIMOD HYDROCHLORIDECelgene Corporation93ce2fab-edfb-4804-8074-963071de51e42026-04-16Warnings, Adverse reactionsExact identifier
rxcui: 2288431

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
93ce2fab-edfb-4804-8074-963071de51e4Zeposia 37-Day Starter Kit (7-Day Starter Pack and 0.92 MG 30 count Bottle)SY25These highlights do not include all the information needed to use ZEPOSIA safely and effectively. See full prescribing information for ZEPOSIA. ZEPOSIA ® (ozanimod) capsules, for oral use Initial U.S. Approval: 202020260416
93ce2fab-edfb-4804-8074-963071de51e4{4 (ozanimod 0.23 MG Oral Capsule [Zeposia]) / 3 (ozanimod 0.46 MG Oral Capsule [Zeposia]) / 30 (ozanimod 0.92 MG Oral Capsule [Zeposia]) } Pack [Zeposia 37-Day Starter Kit]BPCK25These highlights do not include all the information needed to use ZEPOSIA safely and effectively. See full prescribing information for ZEPOSIA. ZEPOSIA ® (ozanimod) capsules, for oral use Initial U.S. Approval: 202020260416
93ce2fab-edfb-4804-8074-963071de51e4ZEPOSIA 37-Day Starter KitPSN25These highlights do not include all the information needed to use ZEPOSIA safely and effectively. See full prescribing information for ZEPOSIA. ZEPOSIA ® (ozanimod) capsules, for oral use Initial U.S. Approval: 202020260416